Dr. Laura Anne Lee, MD

Dr. Lee practices at Desert Regional Medical Center in Palm Springs, California, part of Tenet Healthcare.

Dr. Lee's NPI, 1568545374, was assigned on October 23, 2006. Dr. Lee graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1992. Dr. Lee holds California license G87497.

Dr. Lee's primary practice is Desert Regional Medical Center, at 1150 North Indian Canyon Drive, Palm Springs, CA 92262 in Riverside County. The practice phone is (760) 323-6511.

Dr. Lee's primary practice is Desert Regional Medical Center in Palm Springs, California, part of Tenet Healthcare. Dmand AI also links Dr. Lee to 1 hospital, named with a free account. Dr. Lee's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 2 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Lee's licenses on file in 5 states: California, Virginia, Alabama, New Jersey and Pennsylvania.

Dmand AI lists mastectomy among the conditions Dr. Lee treats.

CMS data shows 63 Medicare services from Dr. Lee across 2 procedure codes in 2024, all of them office visits, for 58 Medicare patients. Medicare paid $4,016 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 58 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have cancer, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 58, with 95% women.

In 2024, Dr. Lee wrote 28 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $98 in total drug cost. In 2022, CMS named 18 claims across 1 drug.

Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Lee, published from 2014 to 2022. 2016 was the busiest year, with 3. The most frequent topics are Neoadjuvant Therapy, Receptor, ErbB-2 and Breast Neoplasms. Dr. Lee has published most often in Ann Surg Oncol. Dr. Lee's most frequent co-authors are James V. Pellicane, FACS, MD, Pat W. Whitworth, MD and Peter D. Beitsch, MD.

Dmand AI links Dr. Lee to 3 clinical trials. Conditions studied include Breast Neoplasms and Breast Diseases. Agendia sponsors the most, 3.

CMS Open Payments shows 125 general payments to Dr. Lee from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $943.

Dr. Lee graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1992.

Dr. Lee is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.